RPS3‐Enriched Extracellular Vesicles Mediate Liver‐Spinal Cord Inter‐Organ Communication
Advanced Science · 2026
DOI: 10.1002/advs.202517019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Peiwen Song und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics (Spinal Surgery), The First Affiliated Hospital of Anhui Medical University, Laboratory of Spinal and Spinal Cord Injury Re…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Spinal Cord Injuries, Ribosomal Proteins, Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Anhui Medical University Research Fund Project, Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education.
Abstract (Originalsprache)
Spinal cord injury (SCI) induces bidirectional inter‐organ communication via extracellular vesicles (EVs) with multiple peripheral organs. Here, we identify the liver as a critical regulator that inhibits endogenous neuronal repair. Proteomics of plasma EVs from SCI patients and RNA‐sequence of post‐injury livers revealed a rapid increase of ribosomal protein S3 (RPS3) in plasma EVs and liver‐derived EVs (LEVs). These RPS3‐enriched LEVs are transported to the spinal cord lesion sites, where they are taken up by neural stem cells (NSCs) and astrocytes. Mechanistically, RPS3 activates nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) signaling in recipient cells, inhibiting NSC differentiation into neurons and oligodendrocytes and polarizing astrocytes toward a neuroinflammatory phenotype. Further detection identified activated Kupffer cells (KCs) as the primary source of RPS3, initiating an intra‐hepatic cascade that further amplified RPS3 expression in hepatocytes. Crucially, in vivo depletion of KCs or hepatic RPS3 effectively attenuated NF‐κB activation, restored axonal regeneration and remyelination, and promoted neurological functional recovery. This work highlights a liver‐spinal cord axis wherein RPS3‐enriched hepatic KC‐derived EVs impair central nervous system (CNS) regeneration via the NF‐κB activation, presenting a promising prognostic biomarker and novel therapeutic target for SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics (Spinal Surgery), The First Affiliated Hospital of Anhui Medical University, Laboratory of Spinal and Spinal Cord Injury Regeneration and Repair, The First Affiliated Hospital of Anhui Medical…
- Department of Orthopedics (Spinal Surgery), The First Affiliated Hospital of USTC, Hefei, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
ORCID-Profile: Cailiang Shen
Förderung
- National Natural Science Foundation of China
- Anhui Medical University Research Fund Project
- Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education
Zitieren
APA
Song, P., Wu, Z., Dong, Y., Fang, Y., Bian, S., Wang, D., Fang, H., Liu, Y., Ying, W., Qian, J., Han, T., & Shen, C. (2026). RPS3‐Enriched Extracellular Vesicles Mediate Liver‐Spinal Cord Inter‐Organ Communication. Advanced Science. https://doi.org/10.1002/advs.202517019
Vancouver
Song P, Wu Z, Dong Y, Fang Y, Bian S, Wang D, et al. RPS3‐Enriched Extracellular Vesicles Mediate Liver‐Spinal Cord Inter‐Organ Communication. Advanced Science. 2026. doi:10.1002/advs.202517019
BibTeX
@article{Song2026,
author = {Song, Peiwen and Wu, Zuomeng and Dong, Yixiang and Fang, Yunxiong and Bian, Shiyu and Wang, Daokuan and Fang, Huang and Liu, Yunlei and Ying, Wang and Qian, Jun and Han, Tianyu and Shen, Cailiang},
title = {RPS3‐Enriched Extracellular Vesicles Mediate Liver‐Spinal Cord Inter‐Organ Communication},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202517019}
}
EUVIMED